Burton P Drayer - Radiology | Mount Sinai

Biography

Specialties

Radiology, Neurology

Research

•   CT Scanning
•   MRI (anatomic and functional)
•   Cerebral Infarction
•   Neurodenerative Disease and Normal Aging
•   Vascular Malformation of the Brain
•   Parkinson's Disease
•   Alzheimer's Disease
•   Multiple Sclerosis
•   Brain Neoplasms
•   Brain Iron on MRI
•   Regional Cerebral Blood Flow (Xenon CT)
•   Intrathecal Contrast-Mechanism of Adverse reactions
•   CSF Circulation
•   Magnetic Resonance Angiography (MRA)
•   PET Scanning-Radiation Necrosis vs. Glioma
•   Blood Brain Barrier Integrity
•   Imaging Non-human Primate Models

Education

MD, Chicago Medical School at Rosalind Franklin University

Internship, Internal Medicine, Medical Center Hospital of Vermont

Residency, Neurology, Medical Center Hospital of Vermont

Residency, Diagnostic Radiology, University of Pittsburgh

Fellowship, Neuroradiology, University of Pittsburgh Medical Center

Certifications

American Board of Radiology

American Board of Psychiatry and Neurology

Honors & Awards

2016

Gold Medal

RSNA

2015

Chairman, Radiological Society of North America

RSNA

2011

Gold Medal Award

American Society of Neuroradiology

2011

President

Radiological Society of North America

2011

Board of Chancellors

American College of Radiology

2011

Honorary Member

European Society of Radiology

2011

Honorary Fellow

The Royal College of Surgeons (Ireland)

2009

Best Doctors

New York Magazine

2009

Jacobi Medallion

Mount Sinai Medical Center

2008

Distinguished Service Award

American Board of Radiology

1995

Dr. Charles M. and Marilyn Newman Professor of Radiology

1993

Distinguished Alumnus Award

Chicago Medical School

1977

Cornelius G. Dyke Award

American Society of Neuroradiology

1977

First Prize President's Award

Pittsburgh Roentgen Ray Society

Publications

222

Publications

Selected Publications

Automated detection of critical findings in multi-parametric brain MRI using a system of 3D neural networks. Kambiz Nael, Eli Gibson, Chen Yang, Pascal Ceccaldi, Youngjin Yoo, Jyotipriya Das, Amish Doshi, Bogdan Georgescu, Nirmal Janardhanan, Benjamin Odry, Mariappan Nadar, Michael Bush, Thomas J. Re, Stefan Huwer, Sonal Josan, Heinrich von Busch, Heiko Meyer, David Mendelson, Burton P. Drayer, Dorin Comaniciu, Zahi A. Fayad. Scientific Reports

Impact of COVID-19 social distancing regulations on outpatient diagnostic imaging volumes and no-show rates. Amish H. Doshi, Shingo Kihira, Keon Mahmoudi, Etan Dayan, Tim Carlon, Brett Marinelli, Daryl Goldman, Mark Finkelstein, Bradley N. Delman, Robert Lookstein, Nisha Sullivan, John Hart, Burton P. Drayer. Clinical Imaging

Sources of Revenue Loss and Recovery in Radiology Practices During the Coronavirus Disease 2019 (COVID-19) Pandemic. Timothy Carlon, Mark Finkelstein, Samuel Z. Maron, Daryl Goldman, Shingo Kihira, Brett Marinelli, Etan Dayan, Nisha Sullivan, John Hart, Amish H. Doshi, Bradley N. Delman, Robert Lookstein, Burton P. Drayer. Academic Radiology

View All Publications

Office Locations

Guggenheim Pavilion Floor MC Level

1190 5th Ave

New York, NY 10029

212-241-8333

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Drayer during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

Remedy Logic

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Drayer during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

Remedy Logic

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.